
Smarter CDMO Engagement with AI In Biologics And Cell & Gene Therapy
By Vadim Klyushnichenko, Outsourced Pharma Advisory Board Member In biologics and cell and gene therapy (CGT), selecting and managing Contract Development and Manufacturing Organizations (CDMOs) has become a strategic imperative—but traditional approaches …